All News

Patient Care Guideline Toplines summarize newly revised and updated clinical recommendations from professional societies for convenient, at-a-glance review.

Find a compact sampling of 2022 cardiovascular disease research reviewed on Patient Care, chosen by the editorial staff.

Find a compact sampling of 2022 research on type 2 diabetes and its treatment reviewed on Patient Care, chosen by the editorial staff.

Find a compact sampling of 2022 chronic kidney disease research reviewed on Patient Care, chosen by the editorial staff.

Find a compact sampling of 2022 weight management research reviewed on Patient Care, chosen by the editorial staff.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Peer mentor programs can provide support for patients, especially when it comes to family planning and parenthood.

Data from a phase 1 study of nondependent recreational opioid users suggests cebranopadol has a lower potential for abuse compared to C-II and C-IV opioids

About one-quarter of children with T2D are not obese, according to a meta-analysis, making comprehensive screening essential in the population.

Variable BMI patterns across the lifespan may be a prodromal marker of dementia; a pattern of midlife increase followed by decrease was associated with greatest risk.

Your daily dose of clinical news you may have missed.

The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.

Physiatrist Monica Verduzco-Gutierrez, MD, highlights the state of long COVID management in the US and says primary care is crucial in diagnosing and treating the new condition.

Cardiometabolic disease affects 1 out of every 2 Americans today. This first of 4 quizzes tests your knowledge of how to manage hypertension, heart failure, and renal disease.

Worldwide the report finds that hypertension, hypercholesterolemia, dietary risks, and air pollution are the leading causes of CVD which remains the leading cause of death globally.

The Dexcom G7 continuous glucose monitoring system provides an overall MARD of 8.2%, the highest of any FDA-cleared CGM, the company says.

Your daily dose of clinical news you may have missed.